(Q51541351)
Statements
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties (English)
Jurgen Bajorath
Christian P Larsen
Thomas C Pearson
Paul Tso
Nozomu Shirasugi
Elizabeth Strobert
Dan Anderson
Shannon Cowan
Karen Price
Joseph Naemura
John Emswiler
JoAnne Greene
Lori Ann Turk
Robert Townsend
David Hagerty
Peter S Linsley